Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center (HDC) at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764 Oberschleissheim, Germany.
German Center for Diabetes Research (DZD, Deutsches Zentrum für Diabetesforschung), International Helmholtz Research School for Diabetes, 85764 Oberschleissheim, Germany.
Int J Mol Sci. 2022 Jul 4;23(13):7418. doi: 10.3390/ijms23137418.
Glycosylphosphatidylinositol-anchored proteins (GPI-APs), which are anchored at the outer leaflet of plasma membranes (PM) only by a carboxy-terminal GPI glycolipid, are known to fulfill multiple enzymic and receptor functions at the cell surface. Previous studies revealed that full-length GPI-APs with the complete GPI anchor attached can be released from and inserted into PMs in vitro. Moreover, full-length GPI-APs were recovered from serum, dependent on the age and metabolic state of rats and humans. Here, the possibility of intercellular control of metabolism by the intercellular transfer of GPI-APs was studied. Mutant K562 erythroleukemia (EL) cells, mannosamine-treated human adipocytes and methyl-ß-cyclodextrin-treated rat adipocytes as acceptor cells for GPI-APs, based on their impaired PM expression of GPI-APs, were incubated with full-length GPI-APs, prepared from rat adipocytes and embedded in micelle-like complexes, or with EL cells and human adipocytes with normal expression of GPI-APs as donor cells in transwell co-cultures. Increases in the amounts of full-length GPI-APs at the PM of acceptor cells as a measure of their transfer was assayed by chip-based sensing. Both experimental setups supported both the transfer and upregulation of glycogen (EL cells) and lipid (adipocytes) synthesis. These were all diminished by serum, serum GPI-specific phospholipase D, albumin, active bacterial PI-specific phospholipase C or depletion of total GPI-APs from the culture medium. Serum inhibition of both transfer and glycogen/lipid synthesis was counteracted by synthetic phosphoinositolglycans (PIGs), which closely resemble the structure of the GPI glycan core and caused dissociation of GPI-APs from serum proteins. Finally, large, heavily lipid-loaded donor and small, slightly lipid-loaded acceptor adipocytes were most effective in stimulating transfer and lipid synthesis. In conclusion, full-length GPI-APs can be transferred between adipocytes or between blood cells as well as between these cell types. Transfer and the resulting stimulation of lipid and glycogen synthesis, respectively, are downregulated by serum proteins and upregulated by PIGs. These findings argue for the (patho)physiological relevance of the intercellular transfer of GPI-APs in general and its role in the paracrine vs. endocrine (dys)regulation of metabolism, in particular. Moreover, they raise the possibility of the use of full-length GPI-APs as therapeutics for metabolic diseases.
糖基磷脂酰肌醇锚定蛋白(GPI-APs)仅通过羧基末端 GPI 糖脂锚定于质膜(PM)的外叶,已知在细胞表面具有多种酶和受体功能。先前的研究表明,全长 GPI-AP 与完整的 GPI 锚定物结合可以在体外从 PM 中释放并插入 PM。此外,全长 GPI-AP 可以从血清中回收,这取决于大鼠和人类的年龄和代谢状态。在这里,研究了通过 GPI-AP 的细胞间转移对代谢的细胞间控制的可能性。基于其 PM 中 GPI-AP 表达受损的突变 K562 红细胞白血病(EL)细胞、曼诺胺处理的人脂肪细胞和甲基-β-环糊精处理的大鼠脂肪细胞作为 GPI-AP 的接受细胞,与全长 GPI-AP 一起孵育,从大鼠脂肪细胞制备并嵌入胶束样复合物,或与具有正常 GPI-AP 表达的 EL 细胞和人脂肪细胞作为供体细胞在 Transwell 共培养物中。通过基于芯片的传感检测接受细胞 PM 中全长 GPI-AP 的量增加作为其转移的量度。这两种实验设置均支持糖原(EL 细胞)和脂质(脂肪细胞)合成的转移和上调。所有这些都被血清、血清 GPI 特异性磷脂酶 D、白蛋白、活性细菌 PI 特异性磷脂酶 C 或从培养基中耗尽总 GPI-AP 所减少。合成磷酸肌醇聚糖(PIGs)可逆转血清对转移和糖原/脂质合成的抑制作用,PIGs 与 GPI 糖基核心结构非常相似,并导致 GPI-AP 从血清蛋白中解离。最后,大的、富含脂质的供体和小的、脂质含量稍低的接受脂肪细胞在刺激转移和脂质合成方面最有效。总之,全长 GPI-AP 可以在脂肪细胞之间或在血细胞之间以及这些细胞类型之间转移。转移和由此引起的脂质和糖原合成的刺激分别被血清蛋白下调,被 PIGs 上调。这些发现表明 GPI-AP 的细胞间转移一般具有(病理)生理学意义,特别是在旁分泌与内分泌(功能障碍)代谢调节中的作用。此外,它们提出了使用全长 GPI-AP 作为代谢疾病治疗剂的可能性。